New hope for lymphoma patients: trial tests Chemo-Free drug combo
NCT ID NCT07477366
Summary
This study is testing a new combination of immunotherapy drugs for adults with a slow-growing type of B-cell non-Hodgkin lymphoma that has come back or hasn't responded to previous treatments. The goal is to see if this chemotherapy-free approach can control the cancer. About 20 participants will receive the drug combination for up to 36 weeks and then be followed to monitor their response and survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED B-CELL NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.